Format

Send to

Choose Destination
Emerg Radiol. 2019 Sep 12. doi: 10.1007/s10140-019-01724-w. [Epub ahead of print]

The resuscitative endovascular balloon occlusion of aorta (REBOA) device-what radiologists need to know.

Author information

1
Emory University School of Medicine, 100 Woodruff Cir Suite 231, Atlanta, GA, 30322, USA. linzi.brooke.arndt@emory.edu.
2
Emory University Department of Radiology and Imaging Services, 550 Peachtree St NE, Atlanta, GA, 30308, USA.
3
Morehouse School of Medicine, 720 Westview Drive, Atlanta, GA, 30310, USA.
4
Russell H Morgan Department of Radiology and Radiological Science, Johns Hopkins Medicine, 601 N Caroline St, Baltimore, MD, 21287, USA.

Abstract

Resuscitative endovascular balloon occlusion of the aorta (REBOA) is a novel device approved by the Food and Drug administration (FDA) in 2017 as an alternative to resuscitative emergent thoracotomy (RET). Due to advancements in placement of REBOA, including newly validated placement using anatomic landmarks, REBOA is now widely used by interventional radiologists and emergency physicians in acute subdiaphragmatic hemorrhage. Increased use of REBOA necessitates that radiologists are familiar with verification of proper REBOA placement to minimize complications. This review describes the REBOA device, indications, placement, and complications, summarizing the current available literature.

KEYWORDS:

ER-REBOA; REBOA; Resuscitative endovascular balloon occlusion of the aorta; Trauma

PMID:
31515654
DOI:
10.1007/s10140-019-01724-w

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center